Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
Dow
Express Scripts
Mallinckrodt
Moodys
McKinsey

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR BACTROBAN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Bactroban

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00513799 ↗ The Natural History of Community-Associated MRSA Infections and Decolonization Strategies Completed Washington University School of Medicine N/A 2007-03-01 The purpose of this study is to determine the natural history of community-associated Staphylococcus aureus infections in both adult and pediatric patients by monitoring the rate of recurrent infections in those colonized with S. aureus. In addition, this study will evaluate the efficiency of commonly prescribed decolonization measures in patients presenting with S. aureus skin and soft tissue infections.
NCT00626795 ↗ Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) Completed LEO Pharma Phase 2 2008-02-01 An international, multi-centre, prospective three arm parallel-group, phase II proof of concept study comparing the efficacy and safety of two dosage regimens (BID 7 days and TID 7 days) of TD1414 2% cream and one dosage regimen (BID 7 days) of Bactroban┬« (mupirocin) 2% cream in adults and children down to 2 years of age with impetigo or SITL. Furthermore an evaluation of the pharmacokinetics of TD1414 2% cream TID for 7 days will be performed. A total of 664 patients will be enrolled in a stepwise manner according to age groups starting with the oldest age group.
NCT00731783 ↗ Staphylococcus Aureus Decolonization Study Completed Washington University School of Medicine N/A 2008-07-01 The purpose of this study is to determine whether measures to eliminate the Staph germ from the skin of the index patient (with a special ointment and soap) are more effective when performed by everyone in the household rather than the patient alone, and whether these methods are effective in preventing future Staph infections. The investigators hypothesize that there will be a greater number of households who are successful in eradicating the staph germ from the index patient when all members of the household participate than households where only the index patient is treated.
NCT01049438 ↗ A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections Completed Natividad Medical Center N/A 2006-08-01 This clinical trial tests the hypothesis that body decolonization of patients with recurrent community-associated (CA) MRSA infections will significantly reduce the likelihood of recurrent CA-MRSA infection.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Bactroban

Condition Name

Condition Name for Bactroban
Intervention Trials
Staphylococcus Aureus 5
Furunculosis 3
Staphylococcal Skin Infections 3
Surgical Site Infection 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Bactroban
Intervention Trials
Infections 10
Infection 10
Communicable Diseases 9
Staphylococcal Infections 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Bactroban

Trials by Country

Trials by Country for Bactroban
Location Trials
United States 29
Spain 4
China 1
Switzerland 1
South Africa 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Bactroban
Location Trials
Missouri 5
Maryland 3
Texas 2
Michigan 2
Massachusetts 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Bactroban

Clinical Trial Phase

Clinical Trial Phase for Bactroban
Clinical Trial Phase Trials
Phase 4 5
Phase 3 2
Phase 2 3
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Bactroban
Clinical Trial Phase Trials
Completed 16
Recruiting 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Bactroban

Sponsor Name

Sponsor Name for Bactroban
Sponsor Trials
Washington University School of Medicine 4
Johns Hopkins University 2
GlaxoSmithKline 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Bactroban
Sponsor Trials
Other 25
Industry 8
U.S. Fed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
Medtronic
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.